RxMen, a men’s health tech startup based in Delhi, has raised INR 5 crore (about $570,000) in a seed funding round led by Inflection Point Ventures (IPV).
The round also included investments from SPA Family Ventures, Seven Square Ventures, Ankit Goel, and a grant from Prosus Group.
The startup will use the funding to build its brand, launch RxMen products, and open co-branded clinics. The company plans to reach positive earnings (EBITDA) by October 2025.
Shailja Mittal, Founder and CEO of RxMen, said, “At RxMen, our focus has always been on building a clinical, root-cause platform for men’s health. This fundraise helps us strengthen that mission, expanding care beyond sexual health into stress, sleep, hair, skin, and weight, and continue creating a credible ecosystem where men can finally access the right treatment and support.”
Vinay Bansal, Founder, IPV, said, “Often men’s issues related to sexual health, skin and hair are overlooked. Add to it the stigma of discussing such issues publicly makes it very difficult for Indian men to access good quality healthcare and get treatment for their problems. RxMen provides an all in one men’s health platform designed specifically for their needs which addresses these issues in a holistic manner. By offering solutions to challenges that are typically neglected and rarely spoken about, RxMen empowers men to normalize these issues and tackle them with confidence.”
RxMen, founded in 2023 by Shailja Mittal, is a men’s health platform that provides clinic-based treatments for issues like sexual health, hormones, skin, stress, and sleep, focusing on addressing the root causes.
In just 20 months, RxMen has grown its revenue 100 times, reaching a monthly recurring revenue (MRR) of $70,000 in August 2025 and projecting an annual revenue (ARR) of $1.7 million by FY26.
The startup has provided over 30,000 consultations, handling 6,000 per month through 30 specialists in urology, psychiatry, sexology, and therapy.
RxMen has also created a Sexual Health Index (SHI) using 25,000 anonymized consultations, which is now being validated at IIT Jodhpur, with a reported success rate of 95%.
Read more- KKR Acquires Samhwa to Fuel Global Growth in Cosmetic Packaging
